Seth Klarman’s portfolio: Baupost Group 13F holdings

Quarterly SEC 13F-HR filingsCIK 0001061768Latest: Q2 2026

Q3 2014 filing in brief

In its Q3 2014 13F, filed November 14, 2014, Baupost Group reported $5.7B across 27 US positions. The largest: MU (30.8%), LNG (15.6%), VSAT (11.1%), EBAY (6.0%), THERAVANCE INC (5.9%). In the quarter it opened 4 positions, sold out of 1, added to 6 and trimmed 3; positions opened and sold out came to 29.3% of the portfolio's value.

Methodology

Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.

Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.

Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.

Holdings

Filed Nov 14, 2014

  • 4 New
  • 6 Added
  • 3 Trimmed
  • 1 Exited

27 positions at September 30, 2014. Q/Q change compares shares with the preceding quarter.

RowTickerIssuerStatus
1MUMICRON TECHNOLOGY INC$1.8B51.7M30.82%0.0%Held
2LNGCHENIERE ENERGY INC$896M11.2M15.61%+87.0%Added
3VSATVIASAT INC$636M11.5M11.07%0.0%Held
4EBAYEBAY INC$345M6.1M6.01%+37.4%Added
5—THERAVANCE INC$339M19.8M5.90%−2.8%Trimmed
6—KERYX BIOPHARMACEUTICALS INC$252M18.3M4.38%+73.6%Added
7OCN2EUROCWEN FINL CORP$183M7.0M3.19%—New
8PBFPBF ENERGY INC$171M7.1M2.99%+27.7%Added
9ARANTERO RES CORP$151M2.8M2.64%—New
10—THERAVANCE BIOPHARMA INC$140M6.1M2.43%0.0%Held
11VRTVEURVERITIV CORP$118M2.4M2.06%—New
12—CITIGROUP INC$116M122.6M2.03%0.0%Held
13—RF MICRODEVICES INC$113M9.8M1.96%0.0%Held
14—TRIQUINT SEMICONDUCTOR INC$112M5.9M1.95%0.0%Held
15—SUNEDISON SEMICONDUCTOR LTD$80M4.1M1.40%0.0%Held
16—CHIPMOS TECH BERMUDA LTD$74M3.3M1.29%0.0%Held
17NGNOVAGOLD RES INC$66M21.7M1.14%0.0%Held
18—KOSMOS ENERGY LTD$47M4.8M0.82%0.0%Held
19—SYNERON MEDICAL LTD$30M3.0M0.52%−25.1%Trimmed
20KIN1USDKINDRED BIOSCIENCES INC$28M3.0M0.49%+9.0%Added
21—AMERICAN INTL GROUP INC$19M789.0K0.33%0.0%Held
22INVA 2.125 01/15/23THERAVANCE INC$16M17.1M0.29%—New
23—ALLIANCE ONE INTL INC$13M6.4M0.22%0.0%Held
24BYDBOYD GAMING CORP$10M979.5K0.17%−65.0%Trimmed
25ALDWUSDALON USA PARTNERS LP$6M329.2K0.10%0.0%Held
26—NOVACOPPER INC$6M6.0M0.10%+20.0%Added
27AVEOEURAVEO PHARMACEUTICALS INC$4M3.8M0.07%0.0%Held
1 exited position

Positions held in the preceding quarter and absent from this filing. Values and shares are from the preceding quarter.

TickerIssuerPrevious valuePrevious shares
—IDENIX PHARMACEUTICALS INC$1.3B53.3M
Every quarter on file (53)

From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.